Left Menu
Development News Edition

Domestic flight services resume in Mumbai

PTI | New Delhi | Updated: 25-05-2020 16:29 IST | Created: 25-05-2020 16:29 IST
Domestic flight services resume in Mumbai

As many as 20 flights were operated to and from the Mumbai airport till 12:45 pm on Monday after Indian airlines resumed commercial passenger services after two months of COVID-19 lockdown. The airport received around 1,900 passenger, Mumbai International Airport Ltd (MIAL) said in a statement.

The government had on March 25 announced suspension of all commercial passenger flights, following the imposition of a nationwide lockdown. Last week, the government decided to lift restrictions on the operations of the domestic flight services and allowed Indian carriers to recommence one-third of their total flights from each airport.

"As of 12:40 pm Monday, seven flights carrying 266 arrived at the Shivaji Chhatrapati Shivaji Maharaj International Airport (CSMIA) while a total of 1,613 passenger departed in 13 flights to different destinations till 12.45 pm," MIAL said. Budget carrier IndiGo was the first carrier to recommence air services to and from the city airport with the departure of its  flight to Patna at 6.45 am and its first flight arriving from Lucknow at 8.20 am.

Mumbai airport had on Sunday announced it will restart operations with 50 flights per day to begin with, 25 arrivals and 25 departures. It had also urged the passengers above the age of 14 to mandatorily download the Aarogya Setu app to establish safe travel and as part of the SOPs (standard operating procedure) put in place before the recommencement of operations.

CSMIA had also advised passengers above 80 years as well as expectant mothers and passengers with health issues to restrict travelling..



Why COVID-19 is unstoppable in USA despite it being ranked at the top of GHS Index?

Several worst-hit countries such as Italy, France, Spain, the UK, Canada, and Russia have peaked COVID-19 cases in April. Almost all of them have gradually flattened the curve. However, the USA is setting new daily records of infections tha...

COVID-19 seems cooking biggest ever global scam

The increasing number of corruption cases on COVID-19 funds from throughout the world and involvement of high profile persons indicate that the countries cant ignore corruption in their pandemic response programs. This has generated the nee...

Health Management Information Systems lack holistic, integrated, and pandemic resilient character

Being a part of the United Nations system, the World Health Organization WHO deserves its share of rebuke for its alleged failure issue COVID-19 health emergency alerts on appropriate time. However, the pandemic has also exposed loopholes i...

Pride in the time of coronavirus: a welcome move online?

This year is different in many ways not least as celebrations are also taking place against the dramatic backdrop of a global health crisis and a resurgence in grassroots activism following the death of George Floyd in Minneapolis. ...


Latest News

Villages in Bihar's Darbhanga submerge due to flood

Villages near the Kamala river in Bihars Darbhanga district got submerged due to the ongoing monsoon rains resulting in flood, which forced many families to take shelter elsewhere. According to the Chief Officer of the Panchayat, Chakko Sad...

Online grocery's share of UK market set to double, Ocado says

Online grocery shopping will double its share of the UK market over the new few years, building on a huge increase during the coronavirus lockdown, internet supermarket and technology group Ocado forecast on Tuesday. Industry data shows onl...

Airtel BlueJeans video conferencing platform launched by Airtel; teams up with Verizon

Indias second largest mobile operator Bharti Airtel on Tuesday announced the launch of video conferencing platform Airtel BlueJeans in partnership with US telecom giant Verizon. Airtel BlueJeans is a secure, safe platform and we are committ...

Biophore India gets DCGI nod to manufacture COVID drug Favipiravir API

Biophore India Pharmaceuticals, a city-based firm, has received license from the Drug Controller General of India DCGI to manufacture Favipiravir, an active pharmaceutical ingredient API, used in the finished formulation to treat mild to mo...

Give Feedback